Edition:
India

Lonza Group AG (LONN.S)

LONN.S on Virt-X Level 1

307.70CHF
13 Dec 2018
Change (% chg)

CHF-4.60 (-1.47%)
Prev Close
CHF312.30
Open
CHF312.20
Day's High
CHF312.20
Day's Low
CHF305.10
Volume
165,561
Avg. Vol
294,164
52-wk High
CHF342.00
52-wk Low
CHF218.00

Latest Key Developments (Source: Significant Developments)

Lonza Granted U.S. Patent for L-Carnitine in Animal Nutrition
Wednesday, 5 Dec 2018 

Dec 5 (Reuters) - Lonza Group AG ::LONZA HAS BEEN GRANTED U.S. PATENT 10,016,382 FOR L-CARNITINE USE IN PET FOOD FOR ITS BENEFICIAL IMPACT ON PERFORMANCE AND RECOVERY IN ACTIVE DOGS.  Full Article

Lonza, Sartorius Modify Relationship For Supply Of Cell Culture Media
Thursday, 15 Nov 2018 

Nov 15 (Reuters) - Lonza And Sartorius Stedim Biotech Modify Relationship For Supply Of Cell Culture Media ::SARTORIUS STEDIM BIOTECH WILL CONTINUE TO OFFER LONZA MEDIA AND BUFFER PRODUCTS BUT UNDER A NON-EXCLUSIVE AGREEMENT.  Full Article

Lonza Group Signs Agreement To Divest Water Care Business To Platinum Equity
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Lonza Group AG ::LONZA FURTHER STRENGTHENS FOCUS ON ITS HEALTHCARE CONTINUUM STRATEGY BY SIGNING AGREEMENT TO DIVEST WATER CARE BUSINESS TO PLATINUM EQUITY.LONZA TO ACQUIRE LONZA'S WATER CARE BUSINESS AND OPERATIONS FOR USD 630 MILLION.INCLUSION OF FRENCH BUSINESS IN THIS TRANSACTION IS STILL UNDER DISCUSSION.AGREEMENT IS EXPECTED TO CLOSE IN Q1 OF 2019, SUBJECT TO CUSTOMARY CLOSING CONDITIONS.CITI IS ACTING AS FINANCIAL ADVISOR AND JENNER & BLOCK LLP AS LEGAL ADVISOR TO LONZA.GIBSON, DUNN & CRUTCHER LLP IS ACTING AS LEGAL ADVISOR TO PLATINUM EQUITY ON ACQUISITION.  Full Article

Lonza Acquires A Controlling Stake In Octane Biotech
Tuesday, 30 Oct 2018 

Oct 29 (Reuters) - Lonza Group AG ::LONZA ACQUIRES A CONTROLLING STAKE IN OCTANE BIOTECH TO FURTHER DEVELOP COCOONTM AUTOLOGOUS TECHNOLOGY <<>>.ACQUISITION OF A CONTROLLING STAKE IN OCTANE BIOTECH, WITH RIGHT TO ACQUIRE FULL OWNERSHIP.OCTANE ORTHOBIOLOGICS INC. WILL MAINTAIN EXCLUSIVITY TO A CERTAIN SUBSET OF ORTHOPEDIC CLINICAL INDICATIONS FOR USE IN COCOONTM SYSTEM.ACQUISITION FURTHER STRENGTHENS CO'S COMMITMENT TO DRIVE NEXT GENERATION OF MANUFACTURING PATIENT-SPECIFIC AND PERSONALIZED THERAPIES.  Full Article

Lonza - Production In Nansha To Close For Maintenance
Friday, 19 Oct 2018 

Oct 19 (Reuters) - Lonza Group AG ::WILL SHUT DOWN ITS PRODUCTION OF NIACINAMIDE (VITAMIN B3) IN NANSHA (CN) IN DECEMBER 2018 TO PERFORM ROUTINE MAINTENANCE AND PROCESS OPTIMIZATION.  Full Article

Lonza Group Affirms 2022 Guidance at Capital Markets Day
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Lonza Group AG ::CAPITAL MARKETS DAY 2018 OUTLINES SUSTAINABLE GROWTH PLANS THROUGH FOCUS AND INVESTMENT.EXPECTS TO CONTINUE GROWTH TRAJECTORY TOWARD ACHIEVING ITS PREVIOUSLY COMMUNICATED MID-TERM GUIDANCE.MID-TERM GUIDANCE 2022 HAS BEEN CONFIRMED TODAY AND A POSITIVE OUTLOOK GIVEN BEYOND.FOCUS IS ON ORGANIC GROWTH OPPORTUNITIES AND INVESTMENTS ALONG HEALTHCARE CONTINUUM.  Full Article

Lonza Group AG Expands Its Distribution Relationship With Azelis Americas
Monday, 16 Jul 2018 

July 16 (Reuters) - Lonza Group AG ::SAYS LONZA CONSUMER PRODUCT INGREDIENTS EXPANDS ITS DISTRIBUTION RELATIONSHIP WITH AZELIS AMERICAS.SAYS DEAL INCLUDES THE SALE OF HYGIENE AND PRESERVATION PRODUCTS INTO ARIZONA, CALIFORNIA, IDAHO, MONTANA, NEVADA, NEW MEXICO, OREGON, UTAH, WASHINGTON AND WYOMING, WITH CHANGE EFFECTIVE 1 JULY 2018.  Full Article

Lonza ‍expands offerings for early phase biopharmaceutical drug development​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Lonza Group Ag :Says ‍expands service offerings for early phase biopharmaceutical drug development​.  Full Article

Lonza says not planning to sell wood preservation business after fixes
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Lonza Group Ag :Says wood preservation business 'definitely not under a question mark at this time,' when asked if company would consider selling ‍​.Says wood preservation business performance 'dramatically' better than 3-4 years ago when company considered selling it‍​.  Full Article